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Breast hamartoma is a benign lesion of the breast. It is also referred to as lipofibroadenoma, fibroadenolipoma, or adenolipoma based on their predominant components [1]. 
The term hamartoma was first coined by Arrigoni et al., in 1971, 
as a well-circumscribed breast lesion with varying amounts of 
benign epithelial elements, fibrous tissue, and fat [2]. It typically 
occurs in women after 40 years of age and presents as a painless 
lump or unilateral breast enlargement without a lump. It occurs 
due to the benign proliferation of fibrous, fatty, and glandular 
tissue surrounded by a connective tissue capsule [3]. As these 
components are seen in the normal breast, hence, it is called as 
hamartoma.
Macroscopically, they are soft, larger, well-defined, pinkish-
white, and fleshy with an island of yellow fat tissue [3]. Clinically, it 
looks like a giant fibroadenoma. Calcification, ductal hyperplasia, 
apocrine metaplasia, and adenosis may also occur. Rarely, 
lobular or ductal intraepithelial neoplasms are seen. Usually, 
hamartomas are benign, but there can be a possibility of malignant 
transformation also, hence, excision and histological examination 
should be used to rule out the malignant transformation [4]. Simple 
excision is enough for the treatment if there is no coincidental 
epithelial malignant lesion. Many authors consider this entity 
to be underdiagnosed. With the awareness and advancement of 
the diagnostic modalities including mammography, fine-needle 
aspiration cytology (FNAC), ultrasound, and core biopsy, more 
number of hamartomas can be diagnosed. Among these, FNAC 
remains the investigation of choice, but histopathology is the gold 
standard.
CASE REPORT
A 60-year-old patient presented to the department with the 
complaint of a lump in her left breast for 4 months. The patient felt 
the lump while bathing and had no complaints of pain, increase in 
size of the breast or nipple discharge since she noticed the lump. 
Family history was negative for the breast lump.
On examination, her vital parameters were normal. There were 
no pallor, icterus, clubbing, and generalized lymphadenopathy. On 
local examination, a lump of size 5 cm × 4 cm was palpable in the 
lower inferior quadrant of the left breast. It was firm, non-tender, 
and mobile. Nipple-areola complex was normal and there was no 
left axillary lymphadenopathy. The right breast and axilla were 
normal. On systemic examination, her central nervous system, 
cardiovascular system, respiratory system, and per abdomen 
examination were within normal limits.
Her blood investigations such as complete blood count and 
kidney and liver function tests were done which were within 
normal limits. Ultrasound of the breast was performed and 
a well circumscribed, solid lesion without any intralesional 
microcalcification was seen. Internal echotexture was mixed with 
both hyperechoic and hypoechoic components.
Considering the age of the patient, a provisional diagnosis 
of the carcinoma of the left breast was kept. FNAC from the 
lump was done and it was suggestive of a benign cystic lesion. 
Thus, decision to perform the excision of the lump was taken. 
An infra-areolar incision was given, with dissection and excision 
of the lump was done. On gross examination, the swelling was 
cystic with irregular margins. A cut surface of the lump shows 
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the evidence of cystic swelling with clear fluid. Multiple irregular 
soft tissues with whitish and yellowish areas were seen.
The specimen was sent for histopathological examination 
which revealed several irregular tissue fragments showing 
mammary glandular tissue with a prominent lobular arrangement. 
Fibroadipose and fibrous stroma tissue with a presence of papillary 
metaplasia at few places were suggestive of hamartoma of the 
left breast. The patient was discharged and called for follow-up 
after 1, 3, and 6 months which was uneventful and the patient was 
asymptomatic.
DISCUSSION
Breast hamartoma has a variable presentation on sonography, 
which helps for differential diagnosis. Hamartomas occur 
in the same location as the normal tissue (in the tissue of 
its origin) as opposed to choristomas, which grow in other 
tissues. The pathogenesis of hamartomas consists primarily 
of the disorganized replication of normal tissue cells. The 
underlying mechanism for the replication abnormality is not 
fully understood. Hamartomas arise from connective tissue and 
are generally formed of cartilage, fat, and connective tissue 
cells, although they may include many other types of cells. 
Hamartomas grow at the same rate as the organ from whose 
tissue they are made.
Breast hamartoma may present as a painless lump. It is 
difficult to palpate a small lump as it feels like normal breast 
tissue. In Cowden disease, the breast hamartoma is related to 
genetic defect like an autosomal dominant disorder with multiple 
hamartomas of all three germ layers. In Cowden’s disease, 
there is an increased risk of the breast, thyroid, and endometrial 
neoplasia [5]. Our patient did not have Cowden’s disease. Kopans 
et al. have described the ultrasonic findings as sonolucent 
adenomatous tissue interspersed with echogenic septa of fat and 
fibrous tissue [6].
On breast ultrasound or mammography, the examination and 
the diagnosis of hamartoma are confirmed. Mammography shows 
well-defined areas of both soft tissue and lipomatous elements 
surrounded by a thin radiolucent zone [7]. Tissue calcification 
may be an additional finding. The characteristic mammographic 
appearance is a circumscribed mass of mixed fatty and soft 
tissue elements with a thin pseudocapsule [8]. Ultrasound is 
less useful in diagnosing the breast hamartoma. A well-defined 
solid hypoechoic mass with posterior acoustic shadowing and 
radiolucent hollow and compressible lesion is suggestive of 
hamartoma. When a mammographic round mass with a radiolucent 
halo corresponds to an oval heterogeneous mass surrounded by an 
echogenic or echolucent circle on a sonogram, the confirmation 
of hamartoma can be done [9]. Hamartoma is highly compressible 
as this characteristic is related to the overproliferation of matured 
fat-containing normal breast tissues. Black et al. pointed out that 
in their mammographically and clinically detected hamartomas, 
most have heterogeneous echogenicity without posterior acoustic 
shadowing [9].
According to a study by Sevim et al., the breast hamartomas are rare 
benign lesions that may be underdiagnosed due to the categorization 
of hamartomas as fibroadenomas by pathologists. Pathologic 
examinations can show variability from one case to another. Thus, the 
true incidence may be higher than the literature indicates [10]. A case 
series of 14 cases was conducted by Amir et al. and they concluded 
that the breast hamartoma is a rare benign lesion. It is underdiagnosed 
and thus underreported. However, there are increasing rates of breast 
hamartoma diagnoses due to the huge surge of the usage of breast 
diagnostic procedures such as ultrasound and mammography.
Breast hamartomas are rarely associated with malignancies and 
a few cases of breast invasive ductal carcinoma from hamartoma 
were described in the literature; however, the correlation is 
unproven. Total surgical excision is considered curative, but 
recurrence is seen in about 8% of reported cases [11]. Usually, 
total excision is the treatment of choice.
CONCLUSION
More often, the diagnosis of hamartoma is incidental in women 
older than 40 years. Although imaging features may be similar to 
those of fibroadenoma, the definitive diagnosis is only through 
histological diagnosis. Very rarely, the hamartoma can turn into 
the malignant tumor. However, the resection of the hamartoma of 
the breast is always recommended.
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